Search
Dr Khurum Khan

Dr Khurum Khan

Medical oncology 06058214

  • Bupa Platinum consultant
  • Fee assured
  • Open Referral network
Overview
Bupa Platinum consultant
Fee assured
Open Referral network

Specialises in

  • Colon
  • Upper GI

Offers

  • Face-to-face consultations
  • Video and telephone consultations

About me

I am a research-active consultant who trained in medical oncology at the Northern Ireland Cancer Centre and Royal Marsden NHS Foundation Trust London. After working as a Locum consultant at Royal Marsden for 21 months, I took substantive consultant position in Gastrointestinal Oncology at UCLH. I also attends North Middlesex University Hospital (NMUH), where I am the Clinical Lead of Carcinoma of Unknown Primary (CUP) and clinical research in Oncology.

I was awarded Robert McAlpine fellowship and studied mechanisms of response and resistance to targeted therapies in advanced colorectal cancer. I gained MD(Res) degree under supervision of Professor David Cunningham at the Institute of Cancer Research and the Royal Marsden Hospital. I was involved in setup and conduct of large multi-centre academic and translational studies from the time that he spent in full-time research, which included working as trial physician for phase II/III studies in early and advanced gastrointestinal cancers.

In collaboration with Professor Cunningham, I secured funding from industry to run an academic phase II study of a multikinase inhibitor in metastatic refractory colorectal cancer. I also wrote a successful application for NIHR portfolio adoption of this study. My main research interests involve stratification of therapies in patients with gastrointestinal malignancies, by setting up studies of clinical and translational relevance.

I have presented and lectured in international conferences and public forums respectively. I published several high impact papers in peer-reviewed journals including Science, Cancer Discovery, Cancer Cell, Gut, Gastroenterologist, Clinical Cancer Research, Oncogene, Oncologist, BMC Cancer, British Medical Journal (BMJ) and British Journal of Cancer. I also served as expert member of National Research and Ethics Committee.

I have also played an active role in improving the educational experience of the junior doctors nationally. I write questions for MRCP(UK) and Medical Oncology exams, and remain part of the national medical oncology recruitment panel.

Areas of interest

Colon Cancer
Rectal Cancer
Anal Cancer
Carcinoma of Unknown Primary
Oesophageal Cancer
Gastric Cancer
Cholangiocarcinoma (Bile duct Cancer)
Gall Bladder Cancer
Pancreatic Cancer

Medical secretaries

About me
About my work
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0002

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (>50)

    London Clinic (5-50) Harley Street Clinic (1-5)

  • X0004

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (>50)

    Harley Street Clinic (1-5) London Clinic (1-5)

  • X0003

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (>50)

    Harley Street Clinic (1-5)

  • XR917

    Peripherally inserted central venous catheters (PICCs) under x-ray guidance - (1-5)

    London Clinic (1-5)

  • XR180

    Ultrasound guided drainage of fluid collection - (1-5)

    London Clinic (1-5)

Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.